Oversized composite braided biodegradable stents with post-dilatation for pediatric applications: mid-term results of

Jing Sun1, Kun Sun, Kai Bai

  • 1Department of Pediatric Cardiology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. sunkun@xinhuamed.com.cn.

Biomaterials Science
|August 26, 2020
PubMed

Insights

Composite braided biodegradable stents (CBBS) show promise as a metallic stent alternative for pediatric endovascular disease. These PPDO and PCL stents degraded within 12 months, demonstrating comparable properties to metallic stents with improved mid-term outcomes.

Area of Science:

  • Biomaterials Science
  • Vascular Surgery
  • Pediatric Cardiology

Background:

  • Metallic stents are standard for pediatric endovascular disease.
  • Biodegradable alternatives are needed to avoid long-term complications.

Purpose of the Study:

  • To evaluate a composite braided biodegradable stent (CBBS) made from poly p-dioxanone (PPDO) and polycaprolactone (PCL) as an alternative to metallic stents.
  • To assess CBBS properties, degradation, and efficacy in a swine model.

Main Methods:

  • CBBS and metallic WALLSTENTs were implanted in swine abdominal aortas and iliac arteries.
  • Radial force testing and in vitro degradation studies were performed.
  • Angiography and histological examinations were conducted at 1, 4, 6, and 12 months.

Main Results:

  • CBBS demonstrated properties similar to metallic stents after post-dilatation.
  • CBBS degraded within 12 months, showing mild to moderate neointimal hyperplasia and restenosis.
  • Mid-term outcomes of CBBS with post-dilatation were superior to WALLSTENTs.

Conclusions:

  • CBBS are a viable alternative to metallic stents in pediatric endovascular disease.
  • Post-dilatation and appropriate oversizing are crucial for optimal CBBS performance.
  • Further research is needed to optimize stent design and minimize adverse tissue reactions.

Related Concept Videos